Journals / Dicle Tıp Dergisi / 2018 / Cilt: 45 - Sayı: 4

Comparison of factors affecting non-sentinel lymph node positivity and nomogram efficacy in axillary lymph node positive breast cancer

Axiller lenf nodu pozitif meme kanserinde non-sentinel lenf nodu pozitifliğine etki eden faktörler ve nomogramların etkinliğinin karşılaştırılması

Pages
397–406
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Each clinic should determine and use most suitable nomogram or should create own nomogram.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Our aim is to investigate the factors that affect non-sentinel lymph node positivity in patients with axillary lymph node positive breast cancer and to evaluate the effectiveness of Memorial Sloan-Kettering Cancer Center (MSKCC) and Stanford nomograms in our patients group.
📊
Key Findings & Data:Methods: One hundred and twelve invasive breast cancer patients with metastatic sentinel lymph node biopsy (SLNB) who underwent surgery, between January 2008 and August 2011, in Department of General Surgery at Ondokuz Mayıs University School of Medicine were included in the study.
💡
Conclusion & Impact:Each clinic should determine and use most suitable nomogram or should create own nomogram.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Our aim is to investigate the factors that affect non-sentinel lymph node positivity in patients with axillary lymph node positive breast cancer and to evaluate the effectiveness of Memorial Sloan-Kettering Cancer Center (MSKCC) and Stanford nomograms in our patients group. Methods: One hundred and twelve invasive breast cancer patients with metastatic sentinel lymph node biopsy (SLNB) who underwent surgery, between January 2008 and August 2011, in Department of General Surgery at Ondokuz Mayıs University School of Medicine were included in the study. Variables that will be compared with were recorded by using SPSS 15.0 version. Risk factors which effect the non sentinel lymph node positivity were analysed by logistic regression analysis. P < 0.05 was considered as significant. Receiver operating characteristics (ROC) curves for nomograms were created and area under curves (AUC) were computed. AUC values equal to or greater than 0.70 have been accepted as good discrimination for prediction of non-sentinel lymph node metastasis. Results: In univariate analysis, tumor size, presence of multifocality, lenfovascular invasion, metastatic sentinel lymph node with macrometastasis and extracapsular invasion, the ratio of number of metastatic sentinel lymph node to total number of sentinel lymph node were found to be significant. In multivariate analysis, presence of lenfovascular invasion, extracapsul invasion and the ratio of number of metastatic sentinel lymph node to total number of sentinel lymph node were found to be independent factors for metastatic non-sentinel lymph node. For our patients group we conluded that the both of MSKCC and Stanford nomograms were effective. Conclusion: Nomograms are methods to predict the possibility of non sentinel lymphnode metastasis. But they have yet not the ability to replace axillary lymph node dissection. Their effectiveness can be increased by new predictive factors for non-sentinel lymph node positivity. Each clinic should determine and use most suitable nomogram or should create own nomogram.

Özet

Amaç: Amacımız aksiller lenf nodu pozitif meme kanserinde nonsentinel lenf nodu (NSLN) pozitifliğine etki eden faktörleri araştırmak ve hasta grubumuzda Memorial Sloan-Kettering Cancer Center (MSKCC) ve Stanford nomogramlarının etkinliğini karşılaştırmaktır. Yöntemler: 01.01.2008 - 31.08.2011 tarihleri arasında Ondokuz Mayıs Üniversitesi Tıp Fakültesi Genel Cerrahi Kliniği’nde sentinel lenf nodu biyopsisi (SLNB) sonucunda sentinel lenf nodunda metastaz saptanan invaziv meme kanseri olan 112 hasta çalışmaya alındı. Karşılaştırılacak değişkenler SPSS 15.0 versiyonu programından yararlanılarak kaydedildi. Lojistik regresyon analizi ile NSLN pozitifliğine etki eden risk faktörleri araştırıldı. P< 0.05 anlamlılık düzeyi olarak kabul edildi. Her iki nomogram icin “Receiver Operating Characteristics (ROC)” eğrileri oluşturuldu ve eğriler altındaki alanlar(AUC) hesaplandı. AUC değeri 0.70 ve üzerinde hesaplanan yöntem etkin olarak kabul edildi. Bulgular: Tek değişkenli analizde tümör boyutu, multifokalite, lenfovasküler invazyon varlığı, SLN’daki metastazın makrometastaz oluşu, SLN’da kapsül dışı invazyon varlığı ve metastatik SLN sayısının toplam SLN sayısına oranı anlamlı bulundu. Çok değişkenli analizde lenfovasküler invazyon, SLN’da kapsül dışı invazyon ve metastatik SLN sayısının toplam SLN sayısına oranı NSLN metastazı ile ilgili bağımsız prediktif faktörler olarak saptandı. MSKCC ve Stanford nomogramlarının ikisinin de hasta grubumuzda etkin olmakla birlikte MSKCC nomogramının daha etkin olduğu sonucuna vardık. Sonuç: Nomogramlar aksillada NSLN’unda metastataz olasılığı hakkında yol gösterici yöntemlerdir. Ancak henüz aksiller lenf nodu diseksiyonunun (ALND) yerini alacak kapasitede değildirler. NSLN pozitifliğine etki eden yeni prediktif faktörlerin ortaya konulması ile etkinlikleri artırılabilir. Her klinik kendisine en uygun nomogramı belirlemeli ve kullanmalı veya kendi nomogramını oluşturmalıdır.

🔖

Cite This Article

KOCA, B., KURU, B. (2018). Comparison of factors affecting non-sentinel lymph node positivity and nomogram efficacy in axillary lymph node positive breast cancer. Dicle Tıp Dergisi, Cilt: 45 - Sayı: 4, 397–406. https://ajindex.com/articles/190530

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Baring CC, Squires TS, Tang T. Cancer Statistics 1993. CA Cancer J Clin 1993; 43: 4-26.
  2. Silvenberg E, Lubera J, Cancer Statistics 1987, CA Cancer J Clin 1987; 37: 19-24.
  3. Greenlee RT, Murray T, Bolden S, et al. Cancer Statistics 2000. CA Cancer Clin 2000; 50: 7-33.
  4. Dees EC, Lawrence N, Souba WW, et al. Does Information From Axillary Dissection Change Treatment In Clinically Node-Negative Patients With Breast Cancer. Ann Surg 1999; 226: 279-87.
  5. Anderson BO, Austin-Seymour M.M, Gralow JR, et al. A Multidisciplinary Approach to Locoregional Management of the Axilla for Primary Operable Breast Cancer. Cancer Control 1997; 4: 491-9.
  6. Weaver DL, Krag DN, Ashikaga T, et al. Pathologic Analysis of Sentinel and nonsentinel Lymph Nodes In Breast Carcinoma: A Multicenter Study. Cancer 2000; 88: 1099-107.
  7. Barth R.J, Danforth DN, Venzon DJ, et al. Level of Axillary Involvement by Lymph Node Metastases From Breast Cancer is not An Independent Predictor of Survival. Arch Surg 1991;126:574-77.
  8. Arthur Z, Krasnow H, Robert SH. Lymphocintigraphy Revisted. Nucl Med Ann 1999; 76: 17-96. Krag DN. Minimal Access Surgery for Staging Regional Lymph Nodes: The Sentinel Node Concept. Curr Probl Surg 1998; 35: 951-18.
  9. Brenin DR, Morrow M, Moughan J, et al. Manegement Of Axillary Lymph Node In Breast Cancer: A National patterns of Care Study of 17,151 Patients. Ann Surg 1999; 230: 686-91.
  10. Veronesi U, Paganelli G,Viale G. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Eng J Med 2003; 349: 546-53.
  11. Van Zee KJ, Manasseh D, Bevilacqua J, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel lymph node biopsy. Ann Surg Oncol 2003; 10: 1140–51.
  12. Gur AS, Unal B, Ozbek U, et al. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. Eur J Surg Oncol 2010; 36: 30-5.
  13. Kell MR, Burke JP, Barry M, et al. Outcome of axillary staging in early breast cancer: a meta-analysis. Breast Cancer Res Treat 2010; 120: 441-7.
  14. Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer: Ten-year results of a randomized controlled study. Ann Surg 2010; 251: 595- 600. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage br